Clinical Advances in Myelofibrosis From EHA 2023.

Published Date: 01 Jul 2023

Myelofibrosis updates from EHA 2023 cover novel approaches in ruxolitinib-resistant patients, use of BET inhibitors plus JAK inhibitors to deepen response, and luspatercept to treat anemia.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

2.

Immunotherapy after surgery is good for patients with advanced cancer

3.

AI-based liquid biopsy shows promise for detecting brain cancer

4.

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

5.

New BCMA-Directed Therapies Show Promise in Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot